Clinical timelines destroy marketing plans when trials extend 18+ months. Physician adoption requires evidence most marketing teams can't provide. We fix regulatory navigation and evidence-based adoption for life sciences companies.

The Problem

Clinical trial timelines create unpredictable product launch windows

Your marketing team can't plan campaigns when Phase II trials extend 12+ months past projections. FDA approval timing affects everything from investor updates to commercial team hiring. Traditional marketing planning breaks down when product availability depends on clinical milestones nobody can predict.

FDA promotional restrictions limit marketing claims and pre-approval activities

Your marketing team can't promote investigational products or make efficacy claims during clinical development. FDA guidance on promotional materials creates compliance risk that legal review slows every campaign. Marketing becomes reactive instead of strategic. This directly impacts clinical trial enrollment rate, making it harder to justify marketing spend to leadership. Pre-revenue timelines of 5-10 years make traditional marketing metrics irrelevant during development phases

Physician adoption requires clinical evidence and peer validation

Traditional B2B marketing tactics fail when buyers are physicians who need peer-reviewed evidence and clinical validation. Your marketing team treats doctors like B2B buyers when medical practice adoption requires completely different evidence standards and decision processes. This directly impacts investor engagement metrics, making it harder to justify marketing spend to leadership. Scientific credibility requirements mean marketing must be led by subject matter experts, not generalists

How We Help

We embed fractional CXOs who understand FDA promotional guidelines, clinical evidence requirements, and physician adoption psychology. Your fractional leader builds marketing strategies that work within regulatory constraints while preparing for successful commercial launches.

Our biotech CXOs have navigated FDA promotional compliance, structured physician evidence programs, and optimized commercial readiness around clinical trial timelines. We know how to build compliant pre-launch awareness, design evidence-based physician adoption, and manage marketing through unpredictable clinical development.

You get immediate access to life sciences marketing expertise without hiring full-time leadership that costs $400K+ and takes 6+ months to recruit from specialized biotech sector. We start with FDA compliance audit, clinical timeline planning, and physician evidence strategy development.

Within 90 days, you have FDA-compliant marketing processes, clinical milestone-aligned strategies, and physician adoption frameworks that prepare for successful commercial launch whenever FDA approval occurs.

Our approach starts with a thorough assessment of your current growth infrastructure. We review what is working, what is not, and where the highest-impact opportunities are. This diagnostic phase ensures we are solving the right problems before committing resources to execution.

What makes our approach different: embedded leadership model — not external consulting, operator mentality — we own the number, not just the strategy, 90-day sprint approach with clear phase gates. We operate as an extension of your team, not as outside advisors delivering slide decks. The fractional model means you get senior expertise without the overhead of a full-time hire, and the 90-day sprint structure ensures you see measurable progress at every phase.

We build measurement into every engagement from day one. Before we change anything, we establish baseline metrics so progress is tracked against real numbers. Monthly reporting shows what is working, what needs adjustment, and where to invest next. No vanity metrics — only indicators that connect to revenue.

What we deliver

FDA promotional compliance frameworks
Clinical timeline marketing alignment
Physician evidence adoption programs
Pre-launch awareness strategies
Commercial readiness optimization

We fix regulatory navigation and evidence-based adoption for life sciences companies.

Our Methodology

Our methodology starts with a 90-day sprint designed to create immediate impact while building long-term systems. In the first 30 days, we embed with your leadership team to audit existing marketing infrastructure, review performance data, identify quick wins, and understand the competitive landscape specific to your vertical. We interview key stakeholders, review your analytics stack, and map the customer journey from first touch to closed deal.

Days 30-60 focus on strategy development and early execution. We build a prioritized growth roadmap, restructure team roles where needed, and start implementing the highest-impact changes. This phase includes establishing measurement frameworks so we can track progress against real metrics, not vanity numbers.

Days 60-90 shift to full execution mode. Systems are running, the team is aligned, and we're optimizing based on real data. By the end of the sprint, you have a functioning growth engine with clear ownership and accountability — something that works whether we stay on or not.

How We Work

In the first 30 days, we conduct a full marketing and growth audit. This includes reviewing your analytics stack, interviewing key stakeholders, mapping the customer journey, and identifying the three to five highest-impact opportunities. We establish baseline metrics so we can measure progress against real targets.

During days 30-60, we move into strategy development and early execution. We build a prioritized growth roadmap, begin restructuring team roles where needed, and start implementing quick wins identified in the audit phase. Weekly check-ins keep the team aligned and the leadership team informed.

Days 60-90 are full execution mode. Systems are running, the team knows their roles, and we're optimizing based on real performance data. We provide monthly strategy presentations to the leadership team covering what's working, what's not, and what we're changing.

Most engagements run 3-6 months initially. We work 15-25 hours per week embedded with your team — attending leadership meetings, managing agency relationships, and making resource allocation decisions. The goal is to build systems that outlast the engagement.

FDA compliance optimization
Clinical timeline alignment
Physician adoption acceleration
Commercial launch readiness

If your biotech & life sciences company needs fractional cxo leadership, we should talk.

Expand your marketing team output with our experts

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.

Frequently asked questions

How much does a fractional CMO cost for biotech companies?

Fractional biotech CMOs typically cost $22K-$38K monthly depending on clinical stage and FDA complexity. Compare to $450K+ for full-time life sciences marketing executives who understand regulatory compliance and physician adoption.

Do you handle FDA compliance for biotech marketing?

Yes, we understand FDA promotional guidelines, clinical stage restrictions, and compliant marketing strategies for investigational and approved products. We build marketing within regulatory constraints.

Can you help with physician adoption for life sciences products?

Absolutely. We design evidence-based adoption programs, clinical validation strategies, and peer influence systems that drive physician behavior change and product adoption in medical practice.

How long before we see results from a fractional CXO?

Initial diagnostic insights and quick wins typically surface within the first 30 days. Structural improvements — team alignment, measurement frameworks, channel optimization — show measurable impact by day 60-90. Compounding growth effects from systematic changes become clear at the 3-6 month mark. The 90-day sprint is designed to deliver value at every phase, not just at the end.

How does the fractional model work day-to-day?

We work 15-25 hours per week embedded with your team. That includes attending leadership meetings, managing agency relationships, making resource allocation decisions, and building growth systems. Weekly execution check-ins keep the team aligned. Monthly strategy presentations give leadership visibility into progress and priorities. We operate as a member of your team, not an outside consultant.

What makes a fractional CXO different from a marketing consultant?

Consultants give you frameworks and recommendations. Fractional CXOs own the number. We are embedded in your organization, accountable for growth targets, and building systems that work after the engagement ends. The difference is accountability — we don't hand you a deck and walk away. We execute alongside your team and are measured by outcomes.